Literature DB >> 26042882

Management of atrial fibrillation.

Talal Moukabary1, Mario D Gonzalez2.   

Abstract

Atrial fibrillation is a very common clinical problem with a high prevalence that is expected to rise over time because of increasing risk factors (eg, age, obesity, hypertension). This high prevalence is also associated with high cost, because atrial fibrillation represents about 1% of overall health care spending. The management of atrial fibrillation involves multiple facets: (1) management of underlying disease if present and the management of atrial fibrillation risk factors, (2) prevention of thromboembolism, (3) control of the ventricular rate during atrial fibrillation, and (4) restoration and maintenance of normal sinus rhythm.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiarrhythmic drugs; Atrial fibrillation; Catheter ablation; Sinus rhythm; Thromboembolism; Ventricular rate

Mesh:

Substances:

Year:  2015        PMID: 26042882     DOI: 10.1016/j.mcna.2015.02.007

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

1.  Sympathetic responses induced by radiofrequency catheter ablation of atrial fibrillation.

Authors:  Jian Cui; Mario D Gonzalez; Cheryl Blaha; Ashley Hill; Lawrence I Sinoway
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-12-07       Impact factor: 4.733

2.  Comparison of the Efficancy and Complication Rates of the Hybrid Maze, Complete Cox-Maze and Catheter Ablation in the Treatment of Atrial Fibrillation.

Authors:  Ivo K Genev; Lindsey A Tompkins; Manorama M Khare; Farhad Farokhi
Journal:  J Atr Fibrillation       Date:  2017-02-28

3.  Regional collaboration to improve atrial fibrillation care: Preliminary data from the Netherlands heart network.

Authors:  Henricus-Paul Cremers; Cassandra Hoorn; Luc Theunissen; Pepijn van der Voort; Peter Polak; Sylvie de Jong; Dennis van Veghel; Lukas Dekker
Journal:  J Arrhythm       Date:  2019-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.